SATS:NASDAQEchoStar Corporation Analysis

EchoStar (SATS) trades at $108.34, just above its 200‑day SMA but below the 20‑ and 50‑day averages, indicating short‑term weakness. The 20‑day SMA sits near 111, and the MACD is in a bearish configuration, while RSI at 45.8 suggests no oversold condition. Volume is climbing, and the stock holds a support around $104.6 with resistance near $121.6, giving a technical upside of roughly 19% per the computed metric. Fundamentally, the company posted $15 bn of revenue in 2025, a 4.3% decline YoY, and a GAAP loss of $4.19 per share, leaving a negative profit margin of –96.6%. EBITDA remains positive at $1.5 bn, but operating cash flow is negative and free cash flow is –$0.79 bn, underscoring cash‑generation pressure. The balance sheet is heavily leveraged, with $30.96 bn of debt versus $2.98 bn of cash, yielding a debt‑to‑equity ratio above 500.
Despite these challenges, analysts have a consensus “buy” rating and price targets averaging $128‑$129, implying an upside of about 18‑19%. Recent news highlights a pending spectrum sale that could inject fresh capital and help alleviate the debt load, while litigation and profitability hurdles remain. The company’s exposure to 5G, satellite broadband, and international pay‑TV markets provides a strategic growth narrative, yet execution risk is high. The stock’s beta of 1.35 and 30‑day volatility of 46% point to pronounced price swings, reinforcing a high‑risk profile. Overall, the blend of a potential capital infusion, substantial upside, and heavy financial strain creates a mixed picture. Investors should weigh the short‑term technical weakness against the medium‑term catalyst of the spectrum sale before deciding on positioning.